The warehouse retailer is now offering its US members access to prescriptions for GLP-1 weight loss drugs through its low-cost health care partner Sesame.
The warehouse retailer is now offering its US members access to prescriptions for GLP-1 weight loss drugs through its low-cost health care partner Sesame . Some people go to Costco for its $1.50 hot dogs, others for its $179 Ozempic prescriptions. The warehouse retailer is now offering its US members access to prescriptions for GLP-1 weight loss drugs through its low-cost health care partner Sesame .
Costco first partnered with Sesame, a direct-to-consumer health care marketplace that connects medical providers nationwide with consumers, last fall when it began offering its members online health checkups for as low as $29. But about two months after that announcement, Costco and Sesame noticed that about one in five customer inquiries was about weight-loss help and began working on a new program to address that interest, Sesame co-founder and president Michael Botta told CN
Costco Weight Loss Prescriptions GLP-1 Drugs Sesame
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Costco offers eligible members access to GLP-1 weight-loss drugsMembers of the warehouse club can now sign up for a service that offers access to drugs like Ozempic.
Read more »
AI Identifies Two Natural Bioactive GLP-1 CompoundsTwo bioactive, natural-derived compounds, which show activity at the GLP-1R site, may be orally administered with fewer side effects than their pharmaceutical counterparts.
Read more »
Amid Global GLP-1 Shortages, Doctors Prioritize PatientsSome governments are asking clinicians to reserve prescriptions for those with type 2 diabetes.
Read more »
Help Patients Prevent Weight Gain After Stopping GLP-1sCan your patient keep the weight off without the medication? Here are expert-backed ways to help them try.
Read more »
Gaps Found in Appropriate SGLT2, GLP-1 PrescribingA trio of new studies showed that SGLT2 inhibitors and GLP-1 agonists are often not prescribed or accessible to people who could benefit from them.
Read more »